Aldeyra Therapeutics, Inc. (ALDX): Weighted Average Diluted Shares
60.06M
Year ended 2025-12-31
+0.9%
3-year compound annual growth
+21.4%
10-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 60.06M | +1.0% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | 59.48M | +0.9% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | 58.94M | +0.9% | 2025-02-28, From 2023-01-01 |
| 2022-12-31 | 58.41M | +8.1% | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | 54.04M | n/a | 2023-03-09, From 2021-01-01 |
| No annual figure between 2015-12-31 and 2021-12-31. | |||
| 2015-12-31 | 8.63M | +124.2% | 2016-03-30, From 2015-01-01 |
| 2014-12-31 | 3.85M | +350.1% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | 855.5K | n/a | 2015-03-23, From 2013-01-01 |